Clinical Trial Update: PRP for Treatment of Peyronie's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating autologous platelet-rich plasma (PRP) therapy for Peyronie's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: University of Miami | Conditions: Peyronie Disease, Sexual Dysfunction, Physiological | Phase 2 | Status: COMPLETED